Kenton Abel

Kenton Abel is the Chief Executive Officer and President at Object Pharma, Inc. Kenton previously held roles as Of Counsel at StrategyIP, EVP of Intellectual Property at e2Post, and EVP of Intellectual Property and New Technology at Bonti, Inc., a biotech startup focused on developing biologics. Prior to these roles, Kenton worked as a Patent Attorney at Allergan and Xencor, Inc. Kenton has a JD in Intellectual Property from the University of California, Berkeley - School of Law, a Ph.D. in Biochemistry from the University of California, Riverside, and a B.S. in Chemistry from Pacific Union College.